Beta Finch - Pfizer - PFE - EN

Beta Finch - Pfizer - PFE - EN

AI-powered earnings call analysis for Pfizer (PFE). Two AI hosts break down quarterly results, key metrics, and market implications in digestible podcast episodes.

Episodes

August 28, 2026 7 mins
More earnings analysis: https://betafinch.com
Groups: PHARMA (https://betafinch.com/groups/PHARMA)
──────────
ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown! Today we're diving into Pfizer's second quarter 2026 results, and there's a lot to unpack — from a CFO transition to some really important pipeline news. Before we get into it, quick disclaimer: this podcast is AI-generated content for education...
Listen
Watch
Mark as Played
# Beta Finch Podcast Script: Pfizer Q1 2026 Earnings

**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we dive deep into the latest corporate results. I'm Alex, and joining me as always is Jordan. Today we're unpacking Pfizer's Q1 2026 earnings call, and folks, there's quite a bit to unpack here.

Before we dive in, I need to mention that this podcast is AI-generated content for educational and ...
Listen
Watch
Mark as Played
February 22, 2026 1 min
**BETA FINCH PODCAST SCRIPT**

---

**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown where we cut through the noise to bring you what really matters from the latest quarterly reports. I'm Alex.

**JORDAN**: And I'm Jordan. Before we dive in, I want to make sure our listeners know that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should ...
Listen
Watch
Mark as Played
February 22, 2026 44 secs
ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex, and I'm here with my co-host Jordan to dive into Pfizer's Q4 2024 results that just dropped. Before we get started though, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor...
Listen
Watch
Mark as Played
February 22, 2026 1 min
**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown where we turn complex corporate calls into clear insights. I'm Alex, and with me as always is Jordan.

**JORDAN**: Hey everyone! Today we're diving into Pfizer's Q3 2024 earnings, and wow - this was a solid quarter that really shows the pharma giant is hitting its stride post-pandemic.

**ALEX**: Before we jump in, I need to share our mandatory disclaim...
Listen
Watch
Mark as Played
February 16, 2026 2 mins
Stay tuned for AI-powered earnings analysis from Beta Finch.

This episode includes AI-generated content.
Listen
Watch
Mark as Played

Popular Podcasts

    If you've ever wanted to know about champagne, satanism, the Stonewall Uprising, chaos theory, LSD, El Nino, true crime and Rosa Parks, then look no further. Josh and Chuck have you covered.

    Dateline NBC

    Current and classic episodes, featuring compelling true-crime mysteries, powerful documentaries and in-depth investigations. Follow now to get the latest episodes of Dateline NBC completely free, or subscribe to Dateline Premium for ad-free listening and exclusive bonus content: DatelinePremium.com

    The Bobby Bones Show

    Listen to 'The Bobby Bones Show' by downloading the daily full replay.

    The Joe Rogan Experience

    The official podcast of comedian Joe Rogan.

    The Clay Travis and Buck Sexton Show

    The Clay Travis and Buck Sexton Show. Clay Travis and Buck Sexton tackle the biggest stories in news, politics and current events with intelligence and humor. From the border crisis, to the madness of cancel culture and far-left missteps, Clay and Buck guide listeners through the latest headlines and hot topics with fun and entertaining conversations and opinions.

Advertise With Us
Music, radio and podcasts, all free. Listen online or download the iHeart App.

Connect

© 2026 iHeartMedia, Inc.

  • Help
  • Privacy Policy
  • Terms of Use
  • AdChoicesAd Choices